← Eichor
Study identifier: NCT04031456 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Autologous PRP Infusion May Restore Ovarian Function and May Promote Folliculogenesis in POI Patients

Condition: Menopause, Premature · Menopause Related Conditions · Menopausal Syndrome  ·  Sponsor: Genesis Athens Clinic

PhasePhase 2/Phase 3
Planned participants100
Who can joinFemale, 25 Years to 39 Years
Healthy volunteersYes

About this study

Autologous PRP intra ovarian infusion may restore ovarian function, may promote folliculogenesis and may improve patients' hormonal profile in patients presenting with POI.

This description comes directly from the study's public registry record.

Talk to the study team

Mara Simopoulou, PhD  ·  +306979234100  ·  marasimopoulou@hotmail.com

Agni Pantou, MD, PhD Candidate

Always discuss trial participation with your own doctor first.

Locations (1)

Genesis ACAthens, GreeceRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04031456